This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Schering Corporation. Active years: 2001-2004.
Company Filing History:
Years Active: 2001-2004
Title: Janice K Albrecht: Innovator in Hepatitis C Treatment
Introduction
Janice K Albrecht is a prominent inventor based in Winter Park, FL (US). She has made significant contributions to the field of antiviral therapies, particularly in the treatment of chronic hepatitis C infection. With a total of 5 patents to her name, Albrecht's work has had a profound impact on medical treatments for patients.
Latest Patents
One of her latest patents is titled "Ribavirin-pegylated interferon alfa induction HCV combination therapy." This patent discloses a method for treating antiviral treatment-naive patients with chronic hepatitis C infection. The method aims to eradicate detectable HCV-RNA through a combination therapy that includes a therapeutically effective inducing amount of ribavirin and pegylated interferon-alfa. The treatment is designed to lower detectable HCV-RNA significantly and maintain no detectable HCV-RNA for at least 24 weeks after the treatment period. Another notable patent is "Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection." This patent outlines methods for administering a combination therapy of ribavirin and interferon-alpha over a treatment period of 20 to 50 weeks.
Career Highlights
Janice K Albrecht has built her career at Schering Corporation, where she has been instrumental in developing innovative therapies for hepatitis C. Her expertise in antiviral treatments has positioned her as a key figure in the pharmaceutical industry.
Collaborations
Throughout her career, Albrecht has collaborated with notable professionals in her field, including Paul C Grint and Carlos O Stalgis. These collaborations have further enhanced her research and development efforts in antiviral therapies.
Conclusion
Janice K Albrecht's contributions to the field of hepatitis C treatment through her innovative patents and collaborations highlight her significant role as an inventor. Her work continues to influence the development of effective therapies for chronic hepatitis C infection.